Will the Shockwave Medical Deal Be the Jolt JNJ Stock Needs?
On April 5, 2024, Johnson & Johnson NYSE: JNJ announced its intent to acquire Shockwave Medical Inc. NASDAQ: SWAV for $13.1 billion. Under the terms of the proposed deal, JNJ will pay $335 per shar...
FDA Expands J&J's (JNJ) Carvykti Label in Multiple Myeloma
Following the label expansion, J&J's (JNJ) Carvykti is approved as a second-line treatment for adults with relapsed/refractory myeloma. It was initially approved for use as a fifth- or later-line t...
J&J's (JNJ) $13.1B Shockwave Deal to Boost MedTech Cardio
J&J's (JNJ) proposed acquisition of Shockwave Medical (SWAV) is expected to strengthen its Medtech cardiovascular portfolio.
U.S. FDA approves expanded use of J&J's cancer cell therapy
The U.S. Food and Drug Administration on Friday allowed the expanded use of Johnson & Johnson and Legend Biotech's Carvykti cell therapy as an earlier treatment for patients with a type of blood ca...
Acquisition Watch: Time to Buy Johnson & Johnson (JNJ) or ShockWave Medical's (SWAV) Stock?
News of healthcare behemoth Johnson & Johnson (JNJ) acquiring medical device company ShockWave Medical (SWAV) for $13.1 billion made headlines this morning.
J&J Acquires Shockwave Medical to Boost Its Cardiovascular Treatment Portfolio
Johnson & Johnson (JNJ) announced Friday it was buying Shockwave Medical (SWAV) for $13.1 billion in cash, pushing shares of the maker of cardiovascular catheters to near all-time highs.
Johnson & Johnson to acquire medical device company Shockwave Medical for $13.1B
Johnson & Johnson (NYSE:JNJ) (J&J) will bolster its portfolio of medical devices targeting heart disease with its $13.1 billion acquisition of Shockwave Medical. The companies announced on Friday t...
Johnson & Johnson to Buy Shockwave Medical in $13.1 Billion Deal
The healthcare giant said the addition of the medical-device maker would expand its MedTech cardiovascular portfolio.
Johnson & Johnson Buys Shockwave For $13.1 Billion In Latest Cardio Deal
Johnson & Johnson will acquire Shockwave Medical in a deal valued at $13.1 billion, according to a joint statement Friday, the latest acquisition by the pharmaceutical firm over the last two years ...
SWAV Stock Alert: Shockwave Medical Lands Big Buyer in Johnson & Johnson
Johnson & Johnson (NYSE: JNJ ) is buying medical device company Shockwave Medical (NASDAQ: SWAV ) for $13.1 billion. Shockwave makes devices that perform Intravascular Lithotripsy.
Johnson & Johnson To Buy Shockwave Medical For $13.1 Billion
Johnson & Johnson will pay $13.1 billion, or $335 a share, for Shockwave Medical, which has soared in 2024 in part on takeover speculation.
Johnson & Johnson to buy Shockwave Medical for $12.5 billion
Shockwave Medical Inc (NASDAQ: SWAV) is in the green today after Johnson & Johnson (NYSE: JNJ) said it will buy the medical device maker for $12.5 billion. Shockwave Medical stock priced at a premi...
Johnson & Johnson to Buy Shockwave Medical. It's a Cardio Health Play.
Johnson & Johnson is buying the medical-devices maker for a total enterprise value of about $13.1 billion.
Johnson & Johnson to acquire Shockwave Medical in $13.1 billion deal
Johnson & Johnson JNJ, -1.14% has agreed to acquire Shockwave Medical Inc. SWAV, -0.23% in an all-cash deal with an enterprise value of about $13 billion, the companies said Friday. J&J will pay $3...
Johnson & Johnson to buy Shockwave Medical for $12.5 bln
Johnson & Johnson will buy medical device maker Shockwave Medical for about $12.5 billion, the companies said on Friday, helping the healthcare conglomerate boost its portfolio of medical devices.
Related Companies